-

Shareholder Alert: Robbins LLP Reminds Investors Resideo Technologies, Inc. (REZI) Sued for Misleading Shareholders

SAN DIEGO & AUSTIN, Texas--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP reminds investors that a purchaser of Resideo Technologies, Inc. (NYSE: REZI) filed a class action complaint for alleged violations of the Securities Exchange Act of 1934 between October 10, 2018 and October 22, 2019. Resideo Technologies manufactures home automation products, including smart thermostats and security cameras. The Company was formed through a spin-off from parent Honeywell International, Inc.

If you suffered a loss as a result of Resideo's misconduct, click here.

Resideo Technologies, Inc. (REZI) Accused of Misleading Shareholders

According to the complaint, leading up to its spin-off, Resideo touted its "bright future" and strong competitive position, stating that "[its] competitors are the ones that are concerned." Additionally, Honeywell touted that following the spin-off Resideo would be the market leader in home heating, air conditioning controls, and security markets. In reality, despite the Companies' positive representations, Resideo continued to compete with Honeywell in the sale of its products, losing much of its business to its former parent. Resideo also failed to disclose to investors that its Residential Thermal Solutions ("RTS") business was facing supply chain issues that were causing industry-wide declines. Then, on October 22, 2019, Resideo released preliminary financial results for the third quarter, surprising investors by announcing earnings that significantly missed estimates and the replacement of its CFO. On this news, the price of Resideo stock fell $5.73 per share, a decline of over 37%. The stock has yet to recover.

Resideo Technologies, Inc. (REZI) Shareholders Have Legal Options

Contact us to learn more:
Leo Kandinov
(800) 350-6003
lkandinov@robbinsllp.com
Shareholder Information Form

Robbins LLP is a nationally recognized leader in shareholder rights law. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits, and has helped its clients realize more than $1 billion of value for themselves and the companies in which they have invested. Click here to receive free alerts from Stock Watch when companies engage in wrongdoing.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Leo Kandinov
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
lkandinov@robbinsllp.com
(619) 525-3990 or Toll Free (800) 350-6003
www.robbinsllp.com

Robbins LLP

NYSE:REZI

Release Versions
$Cashtags

Contacts

Leo Kandinov
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
lkandinov@robbinsllp.com
(619) 525-3990 or Toll Free (800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

Stockholder Alert: Robbins LLP Informs Investors of the Flotek Industries, Inc. (FTK) Class Action

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP informs investors that a class action was filed on behalf of all persons and entities who purchased or otherwise acquired Flotek Industries, Inc. (NYSE: FTK) securities between August 3, 2026 and August 17, 2026 (the "Class Period"). Flotek is an energy technology and services company.The complaint alleges that Flotek misled investors by failing to disclose the cancellation of its $400m Puerto Rican deal.Investors who suffered s...

Robbins LLP Encourages WSE Stockholders with Large Losses to Seek Counsel for the Securities Class Action Lawsuit Against Wise Group plc

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds investors that a securities class action has been filed on behalf of all persons and entities that purchased or otherwise acquired Wise Group plc (NASDAQ: WSE) securities between May 11, 2026 and July 23, 2026 (the "Class Period").The complaint alleges that Wise and certain of its senior executives violated the federal securities laws by making materially false and/or misleading statements regarding the Company's anti-money laundering compliance, a...

Robbins LLP Urges Investors of ARS Pharmaceuticals Inc. to Contact the Firm for Information About the SPRY Securities Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds shareholders that a securities class action has been filed on behalf of all investors who purchased or otherwise acquired ARS Pharmaceuticals Inc. (NASDAQ: SPRY) securities between March 9, 2026 and June 24, 2026 (the "Class Period"). ARS is a clinical stage biopharmaceutical company focused on the development and commercialization of neffy for needle-free intranasal delivery of epinephrine for emergency treatment of Type 1 allergic reactions, incl...
Back to Newsroom